Anticoagulation Challenges in Cancer Patients.
作者信息
Khan Muhammad S Y, Ahmad Mahmood
出版信息
JACC CardioOncol. 2021 Jun 15;3(2):339-340. doi: 10.1016/j.jaccao.2021.03.007. eCollection 2021 Jun.
Abstract
摘要
相似文献
1
Anticoagulation Challenges in Cancer Patients.
JACC CardioOncol. 2021 Jun 15;3(2):339-340. doi: 10.1016/j.jaccao.2021.03.007. eCollection 2021 Jun.
2
Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies.癌症患者心血管疾病的抗凝治疗：新旧疗法综述。
Curr Oncol Rep. 2019 Apr 4;21(5):45. doi: 10.1007/s11912-019-0797-z.
3
Challenges of Anticoagulation Management Service and Need of Establishing Pharmacist-Led Anticoagulation Clinic in Tertiary Care Teaching Hospital, Ethiopia: A Qualitative Study.埃塞俄比亚三级护理教学医院抗凝管理服务面临的挑战及设立由药剂师主导的抗凝门诊的必要性：一项定性研究
J Multidiscip Healthc. 2022 Apr 6;15:743-754. doi: 10.2147/JMDH.S359558. eCollection 2022.
4
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.一项旨在为随机对照试验设计提供信息的可行性研究，以确定在癌症相关性血栓形成（ALICAT）治疗中使用低分子量肝素的最具临床和成本效益的抗凝时间：一项混合方法研究的研究方案。
Trials. 2014 Apr 12;15:122. doi: 10.1186/1745-6215-15-122.
5
Improving anticoagulation in sub-Saharan Africa: What are the challenges and how can we overcome them?改善撒哈拉以南非洲地区的抗凝治疗：面临哪些挑战以及我们如何克服这些挑战？
Br J Clin Pharmacol. 2021 Aug;87(8):3056-3068. doi: 10.1111/bcp.14768. Epub 2021 Mar 10.
6
Oral anticoagulation in patients with active cancer and atrial fibrillation: current challenges.癌症合并心房颤动患者的口服抗凝治疗：当前的挑战。
Pol Arch Intern Med. 2020 Oct 29;130(10):878-886. doi: 10.20452/pamw.15315. Epub 2020 Apr 24.
7
Challenges in anticoagulation for patients with brain tumors.脑肿瘤患者抗凝治疗面临的挑战。
Best Pract Res Clin Haematol. 2022 Mar;35(1):101350. doi: 10.1016/j.beha.2022.101350. Epub 2022 Jun 12.
8
A case of a systemic cancer-associated thrombosis successfully treated with multi-disciplinary treatment including anticoagulation therapy and anticancer drug therapy.一例系统性癌症相关血栓形成经包括抗凝治疗和抗癌药物治疗在内的多学科治疗成功治愈。
Eur Heart J Case Rep. 2023 Oct 18;7(11):ytad517. doi: 10.1093/ehjcr/ytad517. eCollection 2023 Nov.
9
Challenges in managing patients on anticoagulation: Thrombocytopenia, resumption after bleeding and recurrent thrombosis.抗凝治疗患者管理中的挑战：血小板减少症、出血后恢复和血栓再发。
J R Coll Physicians Edinb. 2022 Dec;52(4):341-349. doi: 10.1177/14782715221134720. Epub 2022 Nov 1.
10
Challenges of anticoagulation for atrial fibrillation in patients with severe sepsis.严重脓毒症患者心房颤动抗凝治疗的挑战。
Ann Pharmacother. 2013 Oct;47(10):1266-71. doi: 10.1177/1060028013500938.
本文引用的文献
1
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter.癌症合并心房颤动和/或心房扑动患者的抗凝治疗模式
JACC CardioOncol. 2020 Dec 15;2(5):747-754. doi: 10.1016/j.jaccao.2020.09.008. eCollection 2020 Dec.
2
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study.在有和没有癌症的 2,435,541 名房颤患者中，血栓栓塞、死亡率和出血：一项全国性队列研究。
Cancer. 2021 Jun 15;127(12):2122-2129. doi: 10.1002/cncr.33470. Epub 2021 Feb 25.
3
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management.心房颤动合并活动性癌症患者的抗凝治疗：一项关于患者管理的国际调查。
Eur J Prev Cardiol. 2021 May 22;28(6):611-621. doi: 10.1093/eurjpc/zwaa054.
4
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy.心房颤动、血小板减少和血液恶性肿瘤患者的抗凝治疗。
J Thromb Thrombolysis. 2021 Aug;52(2):590-596. doi: 10.1007/s11239-021-02393-8. Epub 2021 Feb 1.
Zotero 插件